Skip to main content
logo
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
19.75
-0.04 (-0.18%)
Oct 28, 2026, 9:38 AM EDT - Market open

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $624.83K in the twelve months ending June 30, 2026, down -97.63% year-over-year. In the year 2025, Silence Therapeutics had annual revenue of $568.83K, down -98.66%.

Revenue (ttm)
$624.83K
Revenue Growth
-97.63%
P/S Ratio
1,936.49
Revenue / Employee
$6,989
Employees
88
Market Cap
1.19B

Revenue Chart

Chart

Revenue by Geography

Chart
  • UK 43.11M 99.7%
  • Germany 144.00K 0.3%
Fiscal year ended Dec 31, 2024 See the full Silence Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025568.83K-41.89M-98.66%
Dec 31, 202442.45M10.81M34.17%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.87M29.01%
Dec 31, 202116.78M9.29M124.07%
Dec 31, 20207.49M7.17M2,215.11%
Dec 31, 2019323.57K--
Dec 31, 2018---
Dec 31, 201721.62K-928.69K-97.72%
Dec 31, 2016950.31K--
Dec 31, 2015---
Dec 31, 201423.37K-170.40K-87.94%
Dec 31, 2013193.77K-70.63K-26.71%
Dec 31, 2012264.40K-812.57K-75.45%
Dec 31, 20111.08M-2.61M-70.75%
Dec 31, 20103.68M893.28K32.03%
Dec 31, 20092.79M-435.52K-13.51%
Dec 31, 20083.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

SLN News

More News